Homoeopathic intervention in prevention of dengue, chikungunya and influenza like illness

Phase 3

Not yet recruiting

• Conditions: Prevention of Dengue, Chikungunya & Influenza like Illnesses

• Registration Number: CTRI/2019/07/020286
• Lead Sponsor: Central Council for Research in Homoeopathy New Delhi

Brief Summary

This shall be comparative cohort studywherein apparently healthy participants will be enrolled from the slum areas.The study shall be conducted at JJ colony of Mayapuri, Piragadi, and Zakira atNew Delhi. There shall be 03 cohorts as below:

 

| | |

| --- | --- |

|Cohort 1

Influenzinum 30 for first 5 weeks followed by Eupatorium perfoliatum 30 for next 5 weeks with information, Education & communication (IEC) for prevention of dengue, chikungunya & ILI.

|Cohort 2

Eupatorium perfoliatum 30 for 10 weeks with IEC for preventive of dengue chikungunya & ILI.

 

|Cohort 3

Only IEC for preventive of dengue chikungunya & ILI.

 Enrolled individuals shall receivehomoeopathic medicine and/or IEC as per their respective cohorts once in weekfor 10 weeks & further shall be under observation till 6 weeks or till theoutbreak is over.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2019-07-22
• Study Start: 2019-07-26

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 30000

Inclusion Criteria

• Healthy individuals of either sex, aged 1year and above living in same community 2.
• Informed consent by head of family 3.
• No symptom of dengue, chikungunya and ILI at the time of enrollment.

Exclusion Criteria

• Symptoms of dengue, chikungunya and ILI/fever in last 7 days at the time of enrolment 2.
• Pregnant women and lactating mother 3.
• Child below the age of 1 year 4.Individuals taking other preventive medicines for dengue, chikungunya and Influenza like illness (ILI) 5.
• Patients with malignancy, immuno-compromised state, life threatening disease, end stage disease.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Changes in incidence of acute febrile illness between the cohorts at weekly interval.	Assessment of the participants every 7 days for 3 months

Secondary Outcome Measures

Name	Time	Method
1. changes in incidence of dengue & chikungunya fever between the cohorts at weekly interval.	2. Changes in incidence of influenza like illness between the cohorts at weekly interval.

Trial Locations

Locations (1)

Central Council for Research in Homoeopathy; 🇮🇳 West, DELHI, India

Central Council for Research in Homoeopathy

🇮🇳West, DELHI, India

Dr Debadatta Nayak

Principal investigator

09873404012

drdnayak@gmail.com